Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             41 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer Olivo, Malini
2012
30 5 p. 624-634
11 p.
artikel
2 Analysis of energy utilization and body composition in kidney, bladder, and adrenal cancer patients Xu, Wen P.
2012
30 5 p. 711-718
8 p.
artikel
3 Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: A novel approach using peptide nucleic acid-mediated, real-time PCR clamping Kim, Eun-Jung
2012
30 5 p. 673-679
7 p.
artikel
4 Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy Mucksavage, Phillip
2012
30 5 p. 590-595
6 p.
artikel
5 Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population? Mandal, Raju Kumar
2012
30 5 p. 555-561
7 p.
artikel
6 Clinical characteristics of bladder urothelial tumors in male patients—the influences of benign prostatic hyperplasia/benign prostatic enlargement Zhang, Nian-zhao
2012
30 5 p. 646-651
6 p.
artikel
7 Commentary on “Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: A meta-analysis of randomized trials.” Nguyen PL, Je Y, Schutz FA, Hoffman KE, Hu JC, Parekh A, Beckman JA, Choueiri TK, Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA Trump, Donald L.
2012
30 5 p. 746-747
2 p.
artikel
8 Commentary on “Comparative effectiveness of axitinib vs. sorafenib in advanced renal cell carcinoma (AXIS): A randomized phase 3 trial.” B.I. Rini, B. Escudier, P. Tomczak, A. Kaprin, C. Szczylik, T.E. Hutson, M.D. Michaelson, V.A. Gorbunova, M.E. Gore, I.G. Rusakov, S. Negrier, Y.C. Ou, D. Castellano, H.Y. Lim, H. Uemura, J. Tarazi, D. Cella, C. Chen, B. Rosbrook, S. Kim, R.J. Motzer Trump, Donald L.
2012
30 5 p. 748-
1 p.
artikel
9 Commentary on “Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomized, placebo-controlled trial.” M.R. Smith, F. Saad, R. Coleman, N. Shore, K. Fizazi, B. Tombal, K. Miller, P. Sieber, L. Karsh, R. Damião, T.L. Tammela, B. Egerdie, H. Van Poppel, J. Chin, J. Morote, F. Gómez-Veiga, T. Borkowski, Z. Ye, A. Kupic, R. Dansey, C. Goessl, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. Trump, Donald L.
2012
30 5 p. 747-
1 p.
artikel
10 Commentary on “Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer.” A.V. D'Amico, M.H. Chen, J. Crook, J.G. Armstrong, S. Malone, A. Steigler, M. Dunne, P.W. Kantoff, J.W. Denham, Brigham and Women's Hospital, Boston, MA. 02115, USA. Trump, Donald L.
2012
30 5 p. 746-
1 p.
artikel
11 Commentary on “Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localized or locally advanced prostate cancer: An analysis of 2 randomized trials.” A.V. D'Amico, M.H. Chen, M. de Castro, M. Loffredo, D.S. Lamb, A. Steigler, P.W. Kantoff, J.W. Denham, Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA Trump, Donald L.
2012
30 5 p. 745-
1 p.
artikel
12 Contents 2012
30 5 p. vi-viii
nvt p.
artikel
13 Course of size and density of metastatic renal cell carcinoma lesions in the early follow-up of molecular targeted therapy Hittinger, Markus
2012
30 5 p. 695-703
9 p.
artikel
14 Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR) Sciarra, Alessandro
2012
30 5 p. 614-619
6 p.
artikel
15 Editorial Board 2012
30 5 p. v-
1 p.
artikel
16 External validation of the cancer of the prostate risk assessment (CAPRA) score in a single-surgeon radical prostatectomy series Loeb, Stacy
2012
30 5 p. 584-589
6 p.
artikel
17 Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder Bi, Jianbin
2012
30 5 p. 688-694
7 p.
artikel
18 HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: A pilot study Asimakopoulos, Anastasios D.
2012
30 5 p. 577-583
7 p.
artikel
19 Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach Zhang, Hongyong
2012
30 5 p. 635-645
11 p.
artikel
20 Information for Authors 2012
30 5 p. IBC-
1 p.
artikel
21 Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer Hara, Noboru
2012
30 5 p. 596-601
6 p.
artikel
22 Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma Fritsche, Hans-Martin
2012
30 5 p. 666-672
7 p.
artikel
23 Masthead 2012
30 5 p. iv-
1 p.
artikel
24 Overview Platz, Elizabeth A.
2012
30 5 p. 727-728
2 p.
artikel
25 Physical activity and urologic cancers Wolin, Kathleen Y.
2012
30 5 p. 729-734
6 p.
artikel
26 Plagiarism Droller, Michael J.
2012
30 5 p. 547-548
2 p.
artikel
27 Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: A case-control study Henríquez-Hernández, Luis Alberto
2012
30 5 p. 660-665
6 p.
artikel
28 Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma Lin, Chang-Te
2012
30 5 p. 680-687
8 p.
artikel
29 Prostate biopsy in patients with long-term use of indwelling bladder catheter: What is the rationale? Antunes, Alberto A.
2012
30 5 p. 620-623
4 p.
artikel
30 Prostate cancer chemoprevention with 5α-reductase inhibitors Nepple, Kenneth G.
2012
30 5 p. 553-554
2 p.
artikel
31 Prostate-specific antigen response after definitive radiotherapy for Skene's gland adenocarcinoma resembling prostate adenocarcinoma Korytko, Timothy P.
2012
30 5 p. 602-606
5 p.
artikel
32 Robotic-assisted vs. open radical prostatectomy: When can we stop the debate? Lavery, Hugh J.
2012
30 5 p. 549-552
4 p.
artikel
33 Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy Sonpavde, Guru
2012
30 5 p. 607-613
7 p.
artikel
34 Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway Ping, Szu-Yuan
2012
30 5 p. 652-659
8 p.
artikel
35 Survey Section Editorial Board 2012
30 5 p. 744-
1 p.
artikel
36 The effect of minimally invasive and open radical prostatectomy surgeon volume Choi, Wesley W.
2012
30 5 p. 569-576
8 p.
artikel
37 The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study Baldazzi, Valentina
2012
30 5 p. 704-710
7 p.
artikel
38 The predominance of benign histology in small testicular masses Shilo, Yaniv
2012
30 5 p. 719-722
4 p.
artikel
39 The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells Ku, Ja Hyeon
2012
30 5 p. 562-568
7 p.
artikel
40 Utility of 18F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes Rosevear, Henry M.
2012
30 5 p. 723-726
4 p.
artikel
41 Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence Pierce, Brandon L.
2012
30 5 p. 735-743
9 p.
artikel
                             41 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland